239 related articles for article (PubMed ID: 36343431)
1. A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the COVID-19 pandemic.
Bradley H; Austin C; Allen ST; Asher A; Bartholomew TS; Board A; Borquez A; Buchacz K; Carter A; Cooper HLF; Feinberg J; Furukawa N; Genberg B; Gorbach PM; Hagan H; Huriaux E; Hurley H; Luisi N; Martin NK; Rosenberg ES; Strathdee SA; Jarlais DCD
Int J Drug Policy; 2022 Dec; 110():103889. PubMed ID: 36343431
[TBL] [Abstract][Full Text] [Related]
2. Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel.
Wiessing L; Sypsa V; Abagiu AO; Arble A; Berndt N; Bosch A; Buskin S; Chemtob D; Combs B; Conyngham C; Feelemyer J; Fitzgerald M; Goldberg D; Hatzakis A; Patrascu RE; Keenan E; Khan I; Konrad S; Leahy J; McAuley A; Menza T; Merrick S; Metcalfe R; Rademaker T; Revivo S; Rosca P; Seguin-Devaux C; Skinner S; Smith C; Tinsley J; Wilberg M; Des Jarlais D
AIDS Behav; 2023 Apr; 27(4):1140-1153. PubMed ID: 36367613
[TBL] [Abstract][Full Text] [Related]
3. Economic Challenges and Behavioral and Mental Health Risks for Overdose during the COVID-19 Pandemic among People Who Inject Drugs.
Williams LD; Lee E; Latkin C; Mackesy-Amiti ME; Kaufmann M; Copulsky E; Kaplan C; Boodram B
Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564746
[TBL] [Abstract][Full Text] [Related]
4. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
[TBL] [Abstract][Full Text] [Related]
5. Unmet need for medication for opioid use disorder among persons who inject drugs in 23 U.S. cities.
Handanagic S; Broz D; Finlayson T; Kanny D; Wejnert C;
Drug Alcohol Depend; 2024 Apr; 257():111251. PubMed ID: 38457965
[TBL] [Abstract][Full Text] [Related]
6. Occupational roles and risks of community-embedded peer educators providing HIV, hepatitis C and harm reduction services to persons who inject drugs in Nairobi, Kenya.
Masese LN; Ludwig-Barron NT; Mbogo L; Guthrie BL; Musyoki H; Bukusi D; Sinkele W; Gitau E; Farquhar C; Monroe-Wise A
PLoS One; 2022; 17(12):e0278210. PubMed ID: 36454881
[TBL] [Abstract][Full Text] [Related]
7. A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives.
May T; Dawes J; Fancourt D; Burton A
Int J Drug Policy; 2022 Aug; 106():103752. PubMed ID: 35653821
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients.
Sivakumar A; Madden L; DiDomizio E; Eller A; Villanueva M; Altice FL
Int J Drug Policy; 2022 Mar; 101():103570. PubMed ID: 34954493
[TBL] [Abstract][Full Text] [Related]
9. Challenges posed by COVID-19 to people who inject drugs and lessons from other outbreaks.
Vasylyeva TI; Smyrnov P; Strathdee S; Friedman SR
J Int AIDS Soc; 2020 Jul; 23(7):e25583. PubMed ID: 32697423
[TBL] [Abstract][Full Text] [Related]
10. HIV Care Continuum Services for People Who Inject Drugs in Kazakhstan During COVID-19: A Qualitative Study of Service Provider Perspectives.
McCrimmon T; Sundelson A; Darisheva M; Gilbert L; Hunt T; Terlikbayeva A; Primbetova S; El-Bassel N
Glob Health Sci Pract; 2022 Apr; 10(2):. PubMed ID: 35487549
[TBL] [Abstract][Full Text] [Related]
11. How has the COVID-19 epidemic affected the risk behaviors of people who inject drugs in a city with high harm reduction service coverage in Vietnam? A qualitative investigation.
Nguyen TT; Hoang GT; Nguyen DQ; Nguyen AH; Luong NA; Laureillard D; Nagot N; Des Jarlais D; Duong HT; Nham TTT; Khuat OTH; Pham KM; Le MS; Michel L; Rapoud D; Le GM
Harm Reduct J; 2022 Jan; 19(1):6. PubMed ID: 35090482
[TBL] [Abstract][Full Text] [Related]
12. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
[TBL] [Abstract][Full Text] [Related]
13. Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.
Lanièce Delaunay C; Maheu-Giroux M; Marathe G; Saeed S; Martel-Laferrière V; Cooper CL; Walmsley S; Cox J; Wong A; Klein MB;
Int J Drug Policy; 2022 May; 103():103627. PubMed ID: 35218989
[TBL] [Abstract][Full Text] [Related]
14. A multimorbidity model for estimating health outcomes from the syndemic of injection drug use and associated infections in the United States.
Chiosi JJ; Mueller PP; Chhatwal J; Ciaranello AL
BMC Health Serv Res; 2023 Jul; 23(1):760. PubMed ID: 37461007
[TBL] [Abstract][Full Text] [Related]
15. "Maintaining HIV and HCV prevention and care for people who inject drugs despite COVID-19 in Hai Phong, Vietnam".
Giang HT; Duc NQ; Molès JP; Vinh VH; Nagot N; Thanh NTT; Huong DT; Oanh KTH; Khue PM; Mai LS; Trang NT; Ngoc PT; Quillet C; Feelemyer J; Vallo R; Michel L; Jarlais DD; Laureillard D; Rapoud D
Int J Drug Policy; 2022 Dec; 110():103870. PubMed ID: 36244242
[TBL] [Abstract][Full Text] [Related]
16. Investigating the sociodemographic and behavioural factors associated with hepatitis C virus testing amongst people who inject drugs in England, Wales and Northern Ireland: A quantitative cross-sectional analysis.
Yuan JM; Croxford S; Viviani L; Emanuel E; Phipps E; Desai M
Int J Drug Policy; 2022 Nov; 109():103821. PubMed ID: 35994940
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of HIV, HBsAg and anti-HCV positivity among people who injected drugs: results of the first bio-behavioral survey using respondent-driven sampling in two urban areas in Mozambique.
Semá Baltazar C; Horth R; Boothe M; Sathane I; Young P; Chitsondzo Langa D; Condula M; Ricardo H; Dengo Baloi L; Cummings B; Schaad N; Gouveia L; Teodoro E; Raymond HF
BMC Infect Dis; 2019 Dec; 19(1):1022. PubMed ID: 31791273
[TBL] [Abstract][Full Text] [Related]
18. Modelling the impact of HIV and HCV prevention and treatment interventions for people who inject drugs in Dar es Salaam, Tanzania.
Fraser H; Stone J; Wisse E; Sambu V; Mfisi P; Duran IJ; Soriano MA; Walker JG; Makere N; Luhmann N; Kafura W; Nouvellet M; Ragi A; Mundia B; Vickerman P
J Int AIDS Soc; 2021 Oct; 24(10):e25817. PubMed ID: 34661964
[TBL] [Abstract][Full Text] [Related]
19. Estimated Number of People Who Inject Drugs in the United States.
Bradley H; Hall EW; Asher A; Furukawa NW; Jones CM; Shealey J; Buchacz K; Handanagic S; Crepaz N; Rosenberg ES
Clin Infect Dis; 2023 Jan; 76(1):96-102. PubMed ID: 35791261
[TBL] [Abstract][Full Text] [Related]
20. M
Martel-Laferrière V; Feaster DJ; Metsch LR; Schackman BR; Loignon C; Nosyk B; Tookes H; Behrends CN; Arruda N; Adigun O; Goyer ME; Kolber MA; Mary JF; Rodriguez AE; Yanez IG; Pan Y; Khemiri R; Gooden L; Sako A; Bruneau J
Trials; 2022 Apr; 23(1):341. PubMed ID: 35461260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
